• Combining oncolytic viruses and dual-specific CAR-T cells for solid tumors
  Richard G. Vile, Mayo Clinic. Minnesota, USA.
• Defining novel therapeutic approaches in Immuno-Oncology
  Olivier Michielin, HUG. Geneva, Switzerland
• Radiotherapy as a combinatorial partner for immunotherapy and targeted therapy in breast cancer
  Lorenzo Galluzzi. Weill Cornell Medical College. New York, USA

Además, FIT Cancer 9 contará con una sesión multidisciplinar sobre el papel de la inmunoterapia en el tratamiento de las metástasis cerebrales en la que el Dr. Hussein Tawbi (MD Anderson Cancer Center. Houston, USA) abordará el tema “Integrating Multidisciplinarity and Emerging Therapies in a brain metastasis-centered tumor board”.